Fig. 1From: Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantationITaLi-Q (panel a) and SF-36 (Panel b) scores at baseline and 6 months after the start of SC HBIG (Wilcoxon signed rank test) HBIG, hepatitis B immunoglobulin; MCS, mental component summary score; PCS, physical component summary score; SC, subcutaneousBack to article page